Reassessing NSF Risk with Modern Contrast

Dr. Lauren Kim speaks with Adarsh Mallepally and Dr. Cory Trankle about their large-scale retrospective study of nearly 4 million patients examining the risk of nephrogenic systemic fibrosis after gadolinium-based contrast administration in those with advanced renal dysfunction. They discuss how modern group 2 and macrocyclic agents were associated with an exceedingly low incidence of NSF, offering important reassurance for evidence-based contrast use and evolving clinical practice. Nephrogenic Systemic Fibrosis in Patients with Advanced RenalDysfunction Following Gadolinium-based Contrast Agents. Mallepally et al. Radiology 2025; 317(3):e251794.

You can listen to Reassessing NSF Risk with Modern Contrast online on Radio and Podcast. Open the player on this page to stream the available audio.

Reassessing NSF Risk with Modern Contrast is an episode from Radiology Podcasts | RSNA by RSNA Podcasts.

This episode is 16:49 long.

This episode was published on Mar 3, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Radiology Podcasts | RSNA when more episodes are available from the podcast feed.